共 50 条
- [31] Portuguese recommendations for the use of biological and targeted synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis-2020 update ARP RHEUMATOLOGY, 2022, 1 (01): : 63 - 82
- [33] Clinical and therapeutic management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: RADAR study Rheumatology International, 2019, 39 : 2015 - 2024
- [35] Disease-Modifying Antirheumatic Drugs and Dementia Prevention: A Systematic Review of Observational Evidence in Rheumatoid Arthritis JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 2024, 11 (05): : 1339 - 1347
- [36] Safety and Efficacy of Biological Disease-Modifying Antirheumatic Drugs in Older Rheumatoid Arthritis Patients: Staying the Distance Drugs & Aging, 2016, 33 : 387 - 398
- [38] COST OF TREATMENT OF RHEUMATOID ARTHRITIS, ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS WITH BIOLOGICAL DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN THE PERIOD 2013-2014 IN BULGARIA JOURNAL OF THE BALKAN TRIBOLOGICAL ASSOCIATION, 2016, 22 (01): : 401 - 409